This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
Additional locations may be listed on ClinicalTrials.gov for NCT06500169.
Locations matching your search criteria
United States
California
Los Angeles
USC / Norris Comprehensive Cancer CenterStatus: Active
Contact: George Salem
Phone: 323-442-3113
Los Angeles General Medical CenterStatus: Active
Contact: George Salem
Phone: 323-442-3113
PRIMARY OBJECTIVES:
I. To recruit, screen, and enroll the intended sample cohort.
II. To examine the safety, feasibility, and adherence, of the 10-week (wk) GREENS program.
III. To analyze the pre-post intervention data and examine the effects (assessed by Hedges g) of the program on:
IIIa. Physical capacity;
IIIb. Psychosocial wellness;
IIIc. Health, and;
IIId. Cognition.
OUTLINE:
Patients participate in the golf training program composed of group sessions over 1-2 hours with a Professional Golfers' Association of America (PGA) professional two times per week for ten weeks. Training consists of complimentary/warm up exercises integrated with pelvic floor muscle training, golf instruction, golf practice, and golf play on a Par 3 public golf course. Patients also wear an activity tracker and undergo blood sample collection on the study.
After completion of study intervention, patients are followed up at 6 months.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUSC / Norris Comprehensive Cancer Center
Principal InvestigatorGeorge Salem
